DEPARTMENT CF HEALTH AND HUMAN SERVICES 
PUBLIC HEALTH SERVICE 
NATIONAL INSTITUTES CF HEALTH 
RECCMBINANT DNA ADVISORY COMMITTEE 
MINUTES OF MEETING 1 
OCTOBER 25, 1982 
The Recombinant ENA Advisory Committee (RAC) was convened for its twenty-sixth 
meeting at 9:00 a.m. on October 25, 1982, in Wilson Hall, Building 1, National 
Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20205. 
Dr. Kenneth Berns (Chairman), University of Florida, presided. In accordance 
with Public Law 92-463, the meeting was open to the public. The following were 
present for all or part of the meeting: 
Committee members (roster attached): 
Winston Brill 
Nina Fedoroff 
David Friedman 
Jean Harris 
King Holmes 
Arthur Landy 
Ad hoc consultants: 
Werner Maas 
David Martin 
Gerard McGarrity 
Robert McKinney 
Robert Mitchell 
Elena Nightingale 
John Scandalios 
Pieter Wens ink 
William J. Gartland, Jr. 
(Executive Secretary) 
Michael Gill, Tufts University 
Susan Gottesman, National Cancer Institute 
James Kaper, University of Maryland 
Non-voting members: 
Howard Berman, Veterans Administration 
Morris Levin, Environmental Protection Agency 
Herman Lewis, National Science Foundation 
Henry Miller, National Center for Drugs and Biologies, FDA 
Sue Tblin, Department of Agriculture 
William Walsh, Department of State 
Other National Institutes of Health staff: 
Stanley Barban, NIAID 
Manuel Barbeito, OD 
W. Qnmett Barkley, OD 
Becky Connors, NIAID 
Irving Delappe, NIAID 
Susan Gerhold, CD News Branch 
John Irwin, OD 
Elizabeth Milewski, NIAID 
Stan Nagle, NIAID 
John Nutter, NIAID 
Bernard Talbot, NIAID 
Robert Wiseberg, NICHD 
1 The RAC is advisory to the NIH, and its recommendations should not be 
considered as final and accepted. The Office of Recombinant ENA Activities 
should be consulted for NIH policy on specific issues. 
